Cullen/Frost Bankers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Sell |
6,423
-445
| -6% | -$234K | 0.04% | 218 |
|
|
2025
Q1 | $4.36M | Buy |
6,868
+561
| +9% | +$356K | 0.06% | 205 |
|
|
2024
Q4 | $4.49M | Buy |
6,307
+5,838
| +1,245% | +$4.16M | 0.06% | 200 |
|
|
2024
Q3 | $493K | Buy |
469
+42
| +10% | +$44.2K | 0.01% | 389 |
|
|
2024
Q2 | $449K | Buy |
427
+101
| +31% | +$106K | 0.01% | 394 |
|
|
2024
Q1 | $314K | Buy |
326
+9
| +3% | +$8.66K | ﹤0.01% | 421 |
|
|
2023
Q4 | $278K | Sell |
317
-20
| -6% | -$17.6K | ﹤0.01% | 439 |
|
|
2023
Q3 | $277K | Buy |
337
+50
| +17% | +$41.1K | ﹤0.01% | 455 |
|
|
2023
Q2 | $206K | Sell |
287
-40
| -12% | -$28.7K | ﹤0.01% | 497 |
|
|
2023
Q1 | $269K | Hold |
327
| – | – | ﹤0.01% | 466 |
|
|
2022
Q4 | $236K | Sell |
327
-31
| -9% | -$22.4K | ﹤0.01% | 479 |
|
|
2022
Q3 | $247K | Buy |
358
+62
| +21% | +$42.8K | 0.01% | 472 |
|
|
2022
Q2 | $175K | Sell |
296
-4
| -1% | -$2.37K | ﹤0.01% | 519 |
|
|
2022
Q1 | $210K | Hold |
300
| – | – | ﹤0.01% | 520 |
|
|
2021
Q4 | $189K | Buy |
300
+4
| +1% | +$2.52K | ﹤0.01% | 543 |
|
|
2021
Q3 | $179K | Buy |
+296
| New | +$179K | ﹤0.01% | 541 |
|
|
2021
Q1 | – | Sell |
-150
| Closed | -$72K | – | 1129 |
|
|
2020
Q4 | $72K | Sell |
150
-117
| -44% | -$56.2K | ﹤0.01% | 633 |
|
|
2020
Q3 | $149K | Buy |
267
+17
| +7% | +$9.49K | ﹤0.01% | 504 |
|
|
2020
Q2 | $156K | Buy |
250
+150
| +150% | +$93.6K | ﹤0.01% | 477 |
|
|
2020
Q1 | $49K | Hold |
100
| – | – | ﹤0.01% | 515 |
|
|
2019
Q4 | $38K | Hold |
100
| – | – | ﹤0.01% | 649 |
|
|
2019
Q3 | $28K | Hold |
100
| – | – | ﹤0.01% | 672 |
|
|
2019
Q2 | $31K | Hold |
100
| – | – | ﹤0.01% | 637 |
|
|
2019
Q1 | $41K | Buy |
+100
| New | +$41K | ﹤0.01% | 589 |
|